Delivery Order SPE2DB20D2014-SPE2DB25FD05H
Award Date 9/18/25
Potential Completion Date 10/9/25
Potential Value $9.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Prevymis 480 mg tablets in packages of seven units. This firm fixed-price delivery order, valued at $4,719.34, represents a non-competitive set-aside award and is scheduled for completion by May 15, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis (letermovir) is an antiviral...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for PREVYMIS 480 mg tablets (7-count units) with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for 480 mg tablets of Prevymis (letermovir), an antiviral medication used in transplant patients. This competitively awarded, firm fixed-price delivery order was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $28,316.04 to AmerisourceBergen Drug Corp for the supply of PREVYMIS 480 mg tablets (quantity 7s) to be performed in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive, non-set-aside procurement. PREVYMIS (letermovir) is an antiviral medication used primarily for cytomegalovirus prophylaxis in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of PREVYMIS (letermovir) 480 mg tablets in quantities of seven units. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $4,719.34, with an ultimate completion date of October 1, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract with a ceiling value of $4,719.34. The contract type is a delivery order with an ultimate completion date of October 7, 2025, and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used to prevent cytomegalovirus infection in immunocompromised patients, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on December 1, 2025. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 22, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised patients, supporting the federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a contract ceiling value of $4,719.34 and an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an...
- The Defense Logistics Agency awarded a $5,256.05 delivery order to AmerisourceBergen Drug Corp for 480 mg Prevymis tablets (seven-count packages) on January 28, 2026, with a completion date of February 19, 2026. This firm fixed-price contract is non-set-aside and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised populations, particularly...